Myant and Coapt Collaborate to Transform Healthcare
In an exciting development for the healthcare industry, Myant Corp, a pioneer in textile computing, has joined forces with Coapt, a leader in neural interface technology. This partnership is set to redefine the assistive technology landscape, focusing on the creation and commercialization of advanced textile-based electromyographic (EMG) interfaces. The core aim is to enhance user interactions with prosthetic limbs and related therapeutic devices, ultimately improving comfort, accuracy, and control for users.
The synergy of Coapt's cutting-edge EMG decoder control systems with Myant's advanced textile technologies promises to pioneer new products in assistive technology. These innovations may pave the way for groundbreaking therapies targeting phantom limb pain and biofeedback solutions, aligning with Myant's mission to enhance the daily lives and experiences of individuals with unique needs.
Tony Chahine, CEO of Myant, emphasizes the shared vision between Myant and Coapt: "Our goal is to improve quality of life through seamless integration between technology and the human body. This collaboration will push the boundaries of what’s possible in prosthetics and rehabilitation."
Looking forward, both companies have laid out a roadmap for future innovation in assistive technologies, which includes exploring applications of virtual and augmented reality in medical therapies. Their collaborative efforts will also encompass research and clinical trials funded to investigate the broader implications of their combined technologies, benefiting patients globally.
Blair Lock, CEO of Coapt, articulated the vision for this partnership: "Together, Coapt and Myant are creating a future where assistive technologies not only help individuals regain function but also enhance their overall comfort and independence."
Myant is set to showcase its latest innovations at the Consumer Electronics Show (CES) from January 7 to 10, 2025, in Las Vegas. With live demonstrations alongside Coapt, Myant aims to accelerate the adoption of next-generation assistive technologies and establish meaningful connections within the global healthcare community.
About Myant
Myant's mission is to enhance quality of life for everyone, leveraging advancements in AI, medicine, and cutting-edge materials. The company is at the forefront of a new era that enables AI guardians to improve human capabilities through textile interfaces functioning as a connected second skin. This innovation seamlessly integrates into daily life, setting a new standard for interaction with the digital world.
From birth to old age, AI guardians enrich everyday experiences, promote well-being, ensure safety, redefine social connections, and offer universal access to optimal care at all times. Myant experienced significant growth in the EU in 2024, welcoming Dr. Xin Gao, a renowned AI scientist, as General Manager of AI.
For more information, visit
Myant's website.
About Coapt
Coapt, LLC is a private company headquartered in Chicago, with a research subsidiary, Liberating Technologies, Inc., located in Boston. Founded in 2012, Coapt quickly launched Complete Control, a machine-learning-based myoelectric prosthetic control system FDA-approved (Class II). This flagship product, now in its second generation, is the first technology enabling users to intuitively control advanced prosthetic arms and hands. The platform utilizes clinically developed AI to learn and adapt to the user’s unique muscle signal patterns, providing intuitive control by decoding intentions for bionic upper limbs. Coapt's myoelectric pattern recognition products are compatible with over 450 unique configurations of prosthetic limbs.
In addition to its premium product range, Coapt has established profound industrial partnerships and maintains a robust portfolio of academic research.
For more details, please visit
Coapt's website.
Textile Computing™
Myant weaves sensors and actuators into everyday textiles, creating an interface that continuously detects and responds to the human body. The goal is to empower humanity to transform capabilities, proactively manage health, provide timely treatments, and foster better connections with ourselves and the people around us.
Join Myant at CES 2025 at booth 53617, Venetian Expo Convention Center, 201 Sands Ave, Las Vegas, NV 89169, USA.
Media Contact
Charles Andreo
Email: [email protected]